Skip to main content

Contrast Media Acute Renal Failure

  • Chapter
Chronic Renal Disease
  • 118 Accesses

Abstract

Several observations point to the possibility that contrast-induced vascular alterations could be the common pathway for contrast-related cases of acute renal failure. Porter and Associates(1) noted that iothalamate, when injected into the left ventricle of the dog, resulted in an increase in cardiac output and caused a 25% decrease in renal blood flow. When isoosmolar quantities of mannitol were injected, however, the same increase in cardiac output occurred, but renal blood flow increased. Transient decreases in renal plasma flow and glomerular filtration rate occur after large-dose excretory urography.(2–4) In fact, noncontrast hypertonic solutions also produce this effect.(5) The response tends to be biphasic showing initially a transient increase in renal flood flow followed by a more prolonged (10–20%) decrease in renal blood flow which may persist for up to 1 hr.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Porter GA, Kloster FE, Bristow JD: Sequential effect of angiographic contrast agent on canine renal and systemic hemodynamics. Am Heart J 81:80, 1971.

    Article  PubMed  CAS  Google Scholar 

  2. Talner LB, Davidson AJ: Renal hemodynamic effects of contrast media. Invest Rad 3:310, 1968.

    Article  CAS  Google Scholar 

  3. Donaldson IML: Comparison of the renal clearances of inulin and radioactive diatrizoate (“Hypaque”) as measures of the glomerular filtration rate in man. Clin Sci 35:513, 1968.

    PubMed  CAS  Google Scholar 

  4. Gup AK, Schlegel JU: Physiologic effects of high dosage excretory urography. J Urol 100:85, 1968.

    PubMed  CAS  Google Scholar 

  5. Chou CC, Hook JB, Hsieh CP, Burns TD, Dabney JM: Effects of radiopaque dyes on renal vascular resistance. J Lab Clin Med 78:705, 1974.

    Google Scholar 

  6. Russel SB, Sherwood T: Monomer/dimer contrast media in the renal circulation: experimental angiography. Br J Radiol 47:268, 1974.

    Article  Google Scholar 

  7. Morris TW, Katzberg RW, Fischer HW: A comparison of the hemodynamic responses to metrizamide and meglumine/sodium diatrizoate in canine renal angiography. Invest Radiol 13:74, 1978.

    Article  PubMed  CAS  Google Scholar 

  8. Sobin SS, Frasher WG, Johnson G: Nature of adverse reactions to radiopaque agents; preliminary report. JAMA 170:1546, 1959.

    Article  CAS  Google Scholar 

  9. Ekeland A, Uflacker R: Effect of meglumine metrizoate and metrizamide on the microcirculation. Acta Radiol Diag 19:969, 1978.

    CAS  Google Scholar 

  10. Endrich B, Ring J, Intaglietta M: Effect of radiopaque contast media on the microcirculation of the rabbit omentum. Diag Radiol 132:331, 1979.

    CAS  Google Scholar 

  11. Bernstein EF, Evans RL, Blum JA, Avant RF: Further experimental observations concerning the protective action of low molecular weight dextran upon intravenous hypaque toxicity. Radiology 76:260, 1961.

    Google Scholar 

  12. Schiantarelli P, Peroni F, Turone P, Rosati G: Effects of iodinated contrast media on erythrocytes. Invest Radiol 8:199, 1973.

    Article  PubMed  CAS  Google Scholar 

  13. Healy JK: Acute oliguric renal failure associated with multiple myeloma: Report of three cases. Br Med J 1:1126, 1963.

    Article  PubMed  CAS  Google Scholar 

  14. Rees ED, Waugh WH: Factors in renal failure in multiple myeloma. Arch Intern Med 116:400, 1965.

    Article  PubMed  CAS  Google Scholar 

  15. Lasser EC, Lang JH, Zawadski ZA: Contrast media: myeloma protein precipitates in urography. JAMA 198:945, 1966.

    Article  PubMed  CAS  Google Scholar 

  16. Myers GH, Witten DM: Acute renal failure after excretory urography in multiple myeloma. Am J Roentgenol 113:583, 1971.

    Google Scholar 

  17. McQueen EG: The nature of urinary casts. J Clin Pathol 15:367, 1962.

    Article  PubMed  CAS  Google Scholar 

  18. Berdon WE, Schwartz RH, Becker J, Baker DH: Tamm-Horsfall proteinuria. Radiology 92:714, 1969.

    PubMed  CAS  Google Scholar 

  19. Mudge GH: Uricosuric action of Cholangiographic agents: A possible factor in nephrotoxicity. N Engl J Med 284:929, 1971.

    Article  PubMed  CAS  Google Scholar 

  20. Postlethwaite AE, Kelley WN: Uricosuric effect of radiocontrast agents: Study in man of four commonly used preparations. Ann Intern Med 74:845, 1971.

    PubMed  CAS  Google Scholar 

  21. Feldman MA, Goldfarb S, McCurdy DK: Recurrent radiography dye-induced acute renal failure. JAMA 229:72, 1974.

    Article  PubMed  CAS  Google Scholar 

  22. Gelman ML, Rowe JW, Coggins CH, Athanasoulis C: Effects of an angiographic contrast agent on renal function. Cardiovascular Med 4:313, 1979.

    Google Scholar 

  23. Kleinknecht D, Deloux J, Homberg JC: Acute renal failure after intravenous urography: Detection of antibodies against contrast media. Clin Nephrol 2:116, 1974.

    PubMed  CAS  Google Scholar 

  24. Light JA, Perloff LJ, Etheredge EE, Hill G, Spees EK: Adverse effects of meglumine diatrizoate on renal function in the early post-transplant period. Transplantation 20:404, 1975.

    Article  PubMed  CAS  Google Scholar 

  25. Heidemann M, Claes G, Nilson AE: The risk of renal allograft rejection following angiography. Transplantation 21:289, 1976.

    Article  Google Scholar 

  26. Brasch RC, Caldwell JL, Fundenberg HH: Antibodies to radiographic contrast agents. Induction and characterization of rabbit antibody. Invest Radiol 11:1, 1976.

    Article  PubMed  CAS  Google Scholar 

  27. Lasser EC, Lee SH, Fisher E, Fisher B: Some further pertinent considerations regarding the comparative toxicity of contrast materials for the dog kidney. Radiology 78:240, 1962.

    PubMed  CAS  Google Scholar 

  28. Holtas S, Almen T, Tejler L: Proteinuria following nephroangiography. II. Influence of contrast medium and catheterization in dogs. Acta Radiol Diag 19:33, 1978.

    CAS  Google Scholar 

  29. Holtas S, Tejler L: Proteinuria following nephroangiography. IV. Comparison in dogs between ionic and non-ionic contrast media. Acta Radiol Diag 20:13, 1979.

    CAS  Google Scholar 

  30. Teljer L, Almen T, Holtas S: Proteinuria following nephroangiography. I. Clinical experiences. Acta Radiol Diag 18:634, 1977.

    Google Scholar 

  31. Goldstein EJ, Feinfeld DA, Fleischner GM, Elkin M: Enzymatic evidence of renal tubular damage following renal angiography. Radiology 121:167, 1976.

    Google Scholar 

  32. Talner LB, Rushman HN, Coel MN: The effect of renal artery injection of contrast material on urinary enzyme excretion. Invest Radiol 7:311, 1972.

    Article  PubMed  CAS  Google Scholar 

  33. Ziegler TW, Ladens JH, Fanestil DD, Talner LB: Inhibition of active sodium transport by radiographic contrast media. Kidney Int 7:68, 1975.

    Article  PubMed  CAS  Google Scholar 

  34. Moreau JF, Diaz D, Sabato J, Jungers P, Kleinknecht D, Hinglais N, Michel JR: Osmotic nephrosis induced by water soluble triiodinated contrast media in man. Radiology 115:329, 1975.

    PubMed  CAS  Google Scholar 

  35. Blaufox MD, Sanderson DR, Tauxe WN, Wakim KG, Orvis AL, Owen CA Jr: Plasmatic Diatrizoate I131 and glomerular filtration in the dog. Am J Physiol 204:536, 1963.

    PubMed  CAS  Google Scholar 

  36. Denneberg T: Clinical studies of kidney function with radioactive sodium diatrizoate (Hypaque). Acta Med Scand 179(suppl 442):1, 1966.

    Google Scholar 

  37. Stokes JM, Conklin JW, Huntley HC: Measurement of glomerular filtration rate by contrast media containing I131 isotopes. J Urol 87:630, 1962.

    PubMed  CAS  Google Scholar 

  38. Golman K, Denneberg T, Nosslin B: Metrizamide in urography. II. A comparison of 51Cr EDTA clearance and metrizamide clearance in man. Invest Radiol 12:353, 1977.

    Article  PubMed  CAS  Google Scholar 

  39. Golman K, Scient C: Metrizamide in experimental urography. V. Renal excretion mechanism of a non-ionic contrast medium in rabbit and cat. Invest Radiol 11:187, 1976.

    Article  PubMed  CAS  Google Scholar 

  40. Golman K, Almen T: Metrizamide in experimental urography. VI. Effect of renal contrast media on urinary solutes. Acta Pharmacol Toxicol 38:120, 1976.

    Article  CAS  Google Scholar 

  41. McChesney EW: The biotransformation of iodinated radiocontrast agents, in Knoefel PK (ed): International Encyclopedia of Pharmacology and Therapeutics. Section 76. Radio contrast agents. New York, Pergamon Press, Vol 1, 1971, pp 147–163.

    Google Scholar 

  42. Bricker NS, Hlad CJ. Observations on the mechanism of the renal clearance of I131. J Clin Invest 34:1057, 1955.

    Article  PubMed  CAS  Google Scholar 

  43. Cassidy CE: The duration of increased serum iodine concentration after ingestion of Bunamiodyl (Orabilex). J Clin Endocrinol 20:1034, 1960.

    Article  CAS  Google Scholar 

  44. Swartz RD, Rubin JE, Lemming BW, Silva P: Renal failure following major angiography. Am J Med 65:31, 1978.

    Article  PubMed  CAS  Google Scholar 

  45. Harkonen S, Kjellstrand CM: Exacerbation of diabetic renal failure following intravenous pyelography. Am J Med 63:939, 1977.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Plenum Publishing Corporation

About this chapter

Cite this chapter

Cronin, R.E. (1985). Contrast Media Acute Renal Failure. In: Cummings, N.B., Klahr, S. (eds) Chronic Renal Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4826-9_39

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4826-9_39

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4828-3

  • Online ISBN: 978-1-4684-4826-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics